US2020306328A1PendingUtilityA1

Extraction of pharmaceutically active components from plant materials

75
Assignee: GW PHARMA LTDPriority: Aug 14, 2002Filed: Oct 30, 2019Published: Oct 1, 2020
Est. expiryAug 14, 2022(expired)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658B01D 11/0203Y02A50/30A61K 31/352Y02A50/473A61K 36/185Y02A50/481
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament. It also relates to a BDS of given purity, for use in pharmaceutical formulations. In particular it relates to BDS comprising cannabinoids obtained by extraction from cannabis.

Claims

exact text as granted — not AI-modified
1 . A botanical drug substance obtainable from botanical raw material from a high THC containing  cannabis  plant having a THC content, wherein said botanical drug substance is an extract derived from the high THC  cannabis  plant comprising at least 50% THC w/w of extract, no more than 5% CBD as % w/w of the THC content, and no more than 5% cannabinoids other than THC and CBD as % w/w of the THC content. 
     
     
         2 .- 10 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.